Meenakshi Hegde
Baylor College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Meenakshi Hegde as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:56 UTC. Open this list on ClinicalTrials.gov
- Ph1NCT05010564 · Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)Baylor College of Medicine · recruiting · Leukemia, B-Cell · principal investigator
- Ph1NCT04995003 · HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced SarcomaBaylor College of Medicine · recruiting · Sarcoma, HER-2 Protein Overexpression, Osteosarcoma · principal investigator
- Ph1NCT04903080 · HER2-specific Chimeric Antigen Receptor (CAR) T Cells for Children With EpendymomaChildren's Oncology Group · active not recruiting · Ependymoma · study chair
- Ph1NCT02442297 · T Cells Expressing HER2-specific Chimeric Antigen Receptors(CAR) for Patients With HER2-Positive CNS TumorsBaylor College of Medicine · active not recruiting · Brain Tumor, Recurrent, Brain Tumor, Refractory · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:56 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Modulating the PD-1/PD-L1 checkpoint to promote antitumor activity of HER2 CAR T cells in patients with sarcomaR01CA276684 · NCI · BAYLOR COLLEGE OF MEDICINE · fiscal years 2023 to 2026 · $627,253 awarded in 2026Grant number is on one of their registry trials
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Pediatric Brain Tumor Consortium A multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumorsUM1CA081457 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI Ira J Dunkel, Arzu Onar-Thomas · fiscal years 2014 to 2026Named on NCT04903080
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ependymoma.